[Neuropsychological assessment early after stroke--an overview of diagnostic instruments available in German and introduction of a new screening tool].
S Kaesberg, G R Fink, E Kalbe
https://pubmed.ncbi.nlm.nih.gov/23986457/Actively Recruiting
Led by BDH-Klinik Hessisch Oldendorf · Updated on 2026-04-20
80
Participants Needed
1
Research Sites
39 weeks
Total Duration
Researchers are investigating the relationship between magnesium levels in the blood and cognitive function in adult stroke patients. Cognitive impairments such as memory loss, word-finding difficulties, and problems with orientation and perception are common after stroke. This study focuses on understanding whether low magnesium levels contribute to these cognitive issues, comparing different types of stroke and analyzing stroke severity alongside cognitive outcomes. The study includes stroke patients admitted to a stroke unit. Researchers will measure magnesium concentration in the blood and assess stroke severity using scales like the National Institutes of Health Stroke Scale, Scandinavian Stroke Scale, and modified Rankin Scale. Cognitive abilities will be tested within the first three days using the Klner Neuropsychologische Screening and the Mini Mental Status Test. These assessments and measurements will be repeated at 4 weeks, 3 months, and at the end of the study, which may last up to six months or until discharge from the clinic. Participants will undergo multiple evaluations including blood tests for magnesium, stroke severity scales, and cognitive testing over several months. If the patient receives an MRI scan, their attention network will also be measured. Researchers will track changes in magnesium levels and cognition over time, aiming to identify correlations between magnesium concentration, stroke severity, and cognitive function. The study also monitors complications and length of hospital stay to better understand recovery processes.
CONDITIONS
Magnesium and Cognition After Stroke
S
Simone B Schmidt, Dr.
J
Jens D Rollnik, Prof.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
BDH-Klinik Hessisch Oldendorf
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 days
Participants undergo cognitive assessments and stroke-related measurements including serum magnesium concentration, cognitive tests (Kölner Neuropsychologische Screening and Mini Mental Status Test), and stroke severity scales within the first three days after admission.
1 to 3 visits depending on timing of assessments
Duration - Up to 6 months
Participants are monitored during stroke rehabilitation with repeated assessments of magnesium levels, stroke-related measures, and cognitive tests at approximately 4 weeks, 3 months, and at study end defined by discharge or transfer. Additional MRI scans may be performed if applicable.
3 follow-up visits at 4 weeks, 3 months, and study end
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
S Kaesberg, G R Fink, E Kalbe
https://pubmed.ncbi.nlm.nih.gov/23986457/Xinjie Tu, Huihua Qiu, Shasha Lin...
https://pubmed.ncbi.nlm.nih.gov/30464479/BDH-Klinik Hessisch Oldendorf
Lead Sponsor